Topixantrone hydrochloride

N/A

Report date: 2023/11/30 16:56:45
NME

Base Information

Drug NameTopixantrone hydrochloride
Drug Alias Name托匹生琼topixantronumtopixantrone托吡蒽醌topixantrona +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsProstatic NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCti Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCti Biopharma Corp
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksKEGG